Pranay Dey
Affiliations: | 2017- | Molecular Functional Imaging Lab | ACTREC- Tata Memorial Centre |
Google:
"Pranay Dey"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Joshi M, Dey P, De A. (2023) Recent advancements in targeted protein knockdown technologies-emerging paradigms for targeted therapy. Exploration of Targeted Anti-Tumor Therapy. 4: 1227-1248 |
| Dey P, Gadewal N, De A. (2023) Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer. International Journal of Biological Macromolecules. 242: 124765 |
| Dey P, Joshi M, Mujawar A, et al. (2022) Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer. Cellular Oncology (Dordrecht) |
| Goel S, Dey P, Dahiya D, et al. (2021) A not so worthless attempt to develop primary culture from breast FNAC/CNB samples! Tissue & Cell. 71: 101517 |
| Mal A, Dey P, Hayes RM, et al. (2020) Identification of Potential Phosphorylation in the Cytoplasmic Domain of Epithelial Cell Adhesion Molecule. Acs Omega. 5: 30808-30816 |
| Yan S, Dey P, Ziegler Y, et al. (2020) Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer. Breast Cancer Research and Treatment |
| Dey P, Wang A, Ziegler Y, et al. (2020) Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer. Cancers. 12 |
| Dey P, Kundu A, Han SH, et al. (2020) Biological Evaluation of Oxindole Derivative as a Novel Anticancer Agent against Human Kidney Carcinoma Cells. Biomolecules. 10 |
| Dey P, Rathod M, De A. (2019) Targeting stem cells in the realm of drug-resistant breast cancer. Breast Cancer (Dove Medical Press). 11: 115-135 |